IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Effector Therapeutics Inc

CUSIP: 28202V116 | 38 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Clear Street LLC100
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Clear Street LLC
100$00.0%Agg GrowthLowNew York, NY2025-05-15